Expertise in
3
conditions

Zhongqiu Q. Lin

107 Yanjiang West Road, 
Guangzhou, CN 
Expertise in
3
conditions
107 Yanjiang West Road, 
Guangzhou, CN 

Overview

Zhongqiu Lin practices practicing medicine in Guangzhou, China.

Lin is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Cervical Cancer, Ovarian Cancer, Myasthenia Gravis, Hysterectomy, and Lymphadenectomy.

They are actively involved in clinical research, co-authoring 101 peer reviewed articles and participating in 2 clinical trials.

Locations

107 Yanjiang West Road, Guangzhou, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Open Label, Multi-Center Phase I/II Study to Evaluate Efficacy and Safety of BGB-290 in Chinese Subjects With Advanced Ovarian Cancer, Fallopian Cancer, and Primary Peritoneal Cancer or Advanced Triple Negative Breast Cancer
An Open Label, Multi-Center Phase I/II Study to Evaluate Efficacy and Safety of BGB-290 in Chinese Subjects With Advanced Ovarian Cancer, Fallopian Cancer, and Primary Peritoneal Cancer or Advanced Triple Negative Breast Cancer
Enrollment Status: Completed
Publish Date: February 04, 2025
Intervention Type: Drug
Study Drug: Pamiparib
Study Phase: Phase 1/Phase 2
A Phase III Multicenter Prospective Randomized Controlled Clinical Trial of HIPEC as NACT and Postoperative Chemotherapy After Interval Debulking Surgery in the Treatment of Advanced-Stage Epithelial Ovarian Cancer
A Phase III Multicenter Prospective Randomized Controlled Clinical Trial of HIPEC as NACT and Postoperative Chemotherapy After Interval Debulking Surgery in the Treatment of Advanced-Stage Epithelial Ovarian Cancer
Enrollment Status: Unknown
Publish Date: January 24, 2018
Intervention Type: Procedure, Drug
Study Drugs: Neoadjuvant Chemotherapy, Adjuvant Chemotherapy
Study Phase: Phase 3
View 1 Less Clinical Trial

101 Total Publications

Sacituzumab govitecan combined with tislelizumab as second-line therapy for recurrent or metastatic cervical cancer: a case report and literature review.
Sacituzumab govitecan combined with tislelizumab as second-line therapy for recurrent or metastatic cervical cancer: a case report and literature review.
Journal: BMC women's health
Published: March 02, 2026

Frequently Asked Questions about Zhongqiu Q. Lin

Is Zhongqiu Q. Lin a top-rated expert for Cervical Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Zhongqiu Q. Lin is classified as an Distinguished expert for Cervical Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Zhongqiu Q. Lin participate in research or clinical trials?

Yes. Zhongqiu Q. Lin has published 101 articles and abstracts on conditions like Cervical Cancer. You can view a list of Zhongqiu Q. Lin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Lin's expertise for a condition
ConditionClose
    View All 15 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile